A combination of two commonly prescribed drugs offers a much more effective treatment for people with debilitating neuropathic pain than if they take either of the medications individually, according to a study by Queen's University researchers.
When given both an anti-seizure drug (gabapentin) and an antidepressant (nortriptyline), patients suffering from neuropathic pain caused by nerve damage or disease experienced less pain than when they took one or the other individually, reports Dr. Ian Gilron.
Back Pain
Back pain or Backache is common due to poor posture, postural deformities and life style. Back pain can be classified anatomically as upper, lower and middle back pain.
Advertisement
"It was also exciting to discover the effect of this combination on sleep interference," added Gilron.
He pointed out that people rated sleep interference with the combined drugs as 1.0 on a scale of 10, compared to 2.2 when they took each drug individually.
![Osteoarthritis]( "Osteoarthritis")
Osteoarthritis is one of the commonest joint disorder and occurs as we age due to wear and tear of a joint. Osteoarthritis can affect any joint of the body.
"That's a very important issue for this group of patients, whose debilitating, unrelenting pain often interferes with normal sleep," he said.
This is the first time that the researchers have found a drug combination that also helps patients sleep better.
Gilron says that it is important to understand how drugs interact, since 45 per cent of Canadians being treated for neuropathic pain take two or more pain drugs.
There may also be safety issues.
"We need more evidence from carefully conducted trials in support of each particular combination, and let the doctors and patients know about such results," said Gilron.
The methodology behind the treatment could also be applied to the study of other chronic conditions such as cancer-related pain, spinal disk disease, and the pain experienced after chemotherapy and mastectomies, said Gilron.
The study's findings have been published in The Lancet.
Source: ANI
SRM
Osteoarthritis
Osteoarthritis is one of the commonest joint disorder and occurs as we age due to wear and tear of a joint. Osteoarthritis can affect any joint of the body.
Advertisement
"That's a very important issue for this group of patients, whose debilitating, unrelenting pain often interferes with normal sleep," he said.
This is the first time that the researchers have found a drug combination that also helps patients sleep better.
Gilron says that it is important to understand how drugs interact, since 45 per cent of Canadians being treated for neuropathic pain take two or more pain drugs.
There may also be safety issues.
"We need more evidence from carefully conducted trials in support of each particular combination, and let the doctors and patients know about such results," said Gilron.
The methodology behind the treatment could also be applied to the study of other chronic conditions such as cancer-related pain, spinal disk disease, and the pain experienced after chemotherapy and mastectomies, said Gilron.
The study's findings have been published in The Lancet.
Source: ANI
SRM
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Drug News
Examining FDA and patent records, researchers found that insulin manufacturers prolong market exclusivity for brand-name products.
The rise in FDA ODD awards indicates a collective endeavor to create new myelofibrosis medications devoid of mechanisms inducing anemia.
The most significant decrease in autoimmune thyroid disease risk was observed in rheumatoid arthritis patients receiving immunomodulatory drugs or 'biological DMARDs'.
Human apotransferrin injected to mice models suffering from intracerebral hemorrhage was found to mitigate the serious effects of stroke.
The reduction of these senescent osteoclasts, possibly through the utilization of current medications, could present a novel approach in managing lower back pain.